Biodyne Co., Ltd. (KOSDAQ:314930)
South Korea · Delayed Price · Currency is KRW 14,080
-300 (-2.09%)
At close: Sep 18, 2025
Biodyne Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Other Revenue | -0 | - | - | - | -0 | - | Upgrade |
| 5,641 | 5,271 | 4,089 | 12,210 | 3,763 | 3,671 | Upgrade | |
Revenue Growth (YoY) | 34.44% | 28.93% | -66.52% | 224.47% | 2.51% | -10.23% | Upgrade |
Cost of Revenue | 2,291 | 2,834 | 3,404 | 2,905 | 3,265 | 3,192 | Upgrade |
Gross Profit | 3,350 | 2,438 | 684.27 | 9,305 | 498.56 | 479.17 | Upgrade |
Selling, General & Admin | 3,387 | 3,027 | 1,829 | 1,828 | 2,122 | 1,600 | Upgrade |
Research & Development | 275.47 | 251.76 | 382.73 | 412.33 | 390.67 | 445.4 | Upgrade |
Other Operating Expenses | 25.26 | 23.41 | 27.52 | 10.57 | 75.88 | 80.92 | Upgrade |
Operating Expenses | 4,855 | 4,168 | 2,735 | 2,622 | 2,842 | 2,306 | Upgrade |
Operating Income | -1,505 | -1,730 | -2,051 | 6,683 | -2,343 | -1,826 | Upgrade |
Interest Expense | -0.16 | -0.17 | -0.22 | -0.44 | -215.23 | -589.5 | Upgrade |
Interest & Investment Income | 597.95 | 587.38 | 718.05 | 439.18 | 63.82 | 3.23 | Upgrade |
Currency Exchange Gain (Loss) | -125.82 | 705.35 | 67.89 | 130.28 | 279.87 | -291.83 | Upgrade |
Other Non Operating Income (Expenses) | -132.21 | -19.12 | -60.94 | 63.19 | -8,923 | -2,636 | Upgrade |
EBT Excluding Unusual Items | -1,166 | -456.37 | -1,326 | 7,316 | -11,138 | -5,341 | Upgrade |
Gain (Loss) on Sale of Investments | 398.73 | 259.52 | 210.85 | 57.77 | - | 257.93 | Upgrade |
Gain (Loss) on Sale of Assets | 58.72 | 55.75 | -105.78 | -7.58 | -0.01 | 22.77 | Upgrade |
Pretax Income | -708.28 | -141.1 | -1,221 | 7,366 | -11,138 | -5,060 | Upgrade |
Income Tax Expense | -232.94 | -151.87 | -229.18 | 1,754 | -281.16 | -605.79 | Upgrade |
Net Income | -475.33 | 10.77 | -991.76 | 5,611 | -10,857 | -4,454 | Upgrade |
Net Income to Common | -475.33 | 10.77 | -991.76 | 5,611 | -10,857 | -4,454 | Upgrade |
Shares Outstanding (Basic) | 31 | 29 | 30 | 30 | 6 | 5 | Upgrade |
Shares Outstanding (Diluted) | 31 | 29 | 30 | 30 | 6 | 5 | Upgrade |
Shares Change (YoY) | 10.52% | -1.92% | 1.23% | 402.08% | 27.04% | 17.60% | Upgrade |
EPS (Basic) | -15.32 | 0.37 | -33.00 | 189.00 | -1836.00 | -957.00 | Upgrade |
EPS (Diluted) | -15.32 | 0.37 | -33.00 | 189.00 | -1836.00 | -957.00 | Upgrade |
Free Cash Flow | -1,425 | 338.26 | -264.7 | 1,151 | -1,341 | -759.85 | Upgrade |
Free Cash Flow Per Share | -45.92 | 11.48 | -8.81 | 38.76 | -226.74 | -163.25 | Upgrade |
Gross Margin | 59.38% | 46.25% | 16.73% | 76.21% | 13.25% | 13.05% | Upgrade |
Operating Margin | -26.69% | -32.81% | -50.16% | 54.73% | -62.27% | -49.75% | Upgrade |
Profit Margin | -8.43% | 0.20% | -24.26% | 45.95% | -288.50% | -121.34% | Upgrade |
Free Cash Flow Margin | -25.25% | 6.42% | -6.47% | 9.43% | -35.63% | -20.70% | Upgrade |
EBITDA | -3.53 | -107.9 | -385.37 | 8,241 | -999.01 | -610.68 | Upgrade |
EBITDA Margin | -0.06% | -2.05% | -9.43% | 67.49% | -26.55% | -16.63% | Upgrade |
D&A For EBITDA | 1,502 | 1,622 | 1,665 | 1,558 | 1,344 | 1,216 | Upgrade |
EBIT | -1,505 | -1,730 | -2,051 | 6,683 | -2,343 | -1,826 | Upgrade |
EBIT Margin | -26.69% | -32.81% | -50.16% | 54.73% | -62.27% | -49.75% | Upgrade |
Effective Tax Rate | - | - | - | 23.82% | - | - | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.